OrbiMed’s Standard BioTools LAB Stock Holding History

OrbiMed’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,819,348	Closed	-$15M	–	154
2021 Q4	$15M	Sell	3,819,348 -780,223	-17%	-$3.06M	0.19%	99
2021 Q3	$30.3M	Sell	4,599,571 -62,300	-1%	-$411K	0.33%	78
2021 Q2	$28.7M	Buy	4,661,871 +62,300	+1%	+$384K	0.29%	81
2021 Q1	$20.8M	Buy	4,599,571 +707,225	+18%	+$3.2M	0.19%	97
2020 Q4	$23.4M	Buy	3,892,346 +338,643	+10%	+$2.03M	0.2%	95
2020 Q3	$26.4M	Buy	3,553,703 +646,603	+22%	+$4.8M	0.33%	77
2020 Q2	$11.7M	Buy	+2,907,100	New	+$11.7M	0.16%	93
2018 Q4	–	Sell	-1,077,801	Closed	-$8.07M	–	136
2018 Q3	$8.07M	Sell	1,077,801 -505,899	-32%	-$3.79M	0.1%	116
2018 Q2	$9.44M	Hold	1,583,700	–	–	0.11%	112
2018 Q1	$9.25M	Hold	1,583,700	–	–	0.11%	104
2017 Q4	$9.33M	Sell	1,583,700 -162,400	-9%	-$957K	0.12%	103
2017 Q3	$8.8M	Hold	1,746,100	–	–	0.08%	106
2017 Q2	$7.05M	Hold	1,746,100	–	–	0.07%	103
2017 Q1	$9.94M	Hold	1,746,100	–	–	0.11%	96
2016 Q4	$12.7M	Hold	1,746,100	–	–	0.16%	78
2016 Q3	$14M	Hold	1,746,100	–	–	0.16%	86
2016 Q2	$15.8M	Hold	1,746,100	–	–	0.16%	78
2016 Q1	$14.1M	Sell	1,746,100 -703,800	-29%	-$5.68M	0.15%	71
2015 Q4	$26.5M	Hold	2,449,900	–	–	0.24%	67
2015 Q3	$19.9M	Hold	2,449,900	–	–	0.2%	74
2015 Q2	$59.3M	Buy	2,449,900 +313,700	+15%	+$7.59M	0.5%	51
2015 Q1	$89.9M	Hold	2,136,200	–	–	0.77%	39
2014 Q4	$72.1M	Buy	2,136,200 +36,000	+2%	+$1.21M	0.69%	40
2014 Q3	$51.5M	Buy	2,100,200 +238,000	+13%	+$5.83M	0.54%	45
2014 Q2	$54.7M	Buy	1,862,200 +415,000	+29%	+$12.2M	0.64%	42
2014 Q1	$63.8M	Buy	1,447,200 +1,192	+0.1%	+$52.5K	0.78%	39
2013 Q4	$55.4M	Buy	1,446,008 +29,400	+2%	+$1.13M	0.81%	40
2013 Q3	$31.1M	Buy	1,416,608 +153,900	+12%	+$3.38M	0.55%	42
2013 Q2	$22M	Buy	+1,262,708	New	+$22M	0.47%	40